A panelist discusses how National Comprehensive Cancer Network (NCCN) guidelines have influenced molecular testing in ovarian cancer, highlighting the importance of biomarkers like BRCA genes for ...

New clinical research has identified a blood test that can reveal which women are more likely to respond to a particular ...

Scientists at The Wistar Institute have solved a longstanding puzzle in ovarian cancer treatment: why anti-estrogen therapy ...

Ovarian cancer, often called the silent killer, presents one of the most serious health threats women face globally. Its subtle symptoms frequently mimic less severe conditions, leading to delayed ...

Women can go into menopause after cancer treatment or surgery. The timing and severity of symptoms can differ from natural ...

Ovarian cancer remains one of the most aggressive gynecological malignancies. Traditional, platinum-based chemotherapy is the standard frontline treatment providing initial benefit for the majority of ...

Immunotherapy has changed the way physicians treat cancer patients. This approach to therapy targets the immune system to redirect cells toward the tumor. Once a tumor is established and begins to ...

Ovarian cancer remains one of the most difficult-to-treat diseases. With all our advances in screening and molecular profiling, it still maintains the worst death-to-diagnosis rate among gynecologic ...

Chemo and surgery failed to treat Diane Davis' advanced cancer. Things seemed hopeless until genetic testing found an ...

Three years ago, a 12-year-old girl walked into a clinic complaining of stomach aches, irregular periods that had been weird ...

A deep spatial proteomic analysis of healthy fallopian tube epithelium, matching high-grade serous ovarian cancer (HGSOC) ...